|
HY-B1484-1mL
|
MedChemexpress LLC
|
Moxalactam (sodium salt) [CAS 64953-12-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-P99034-1mg
|
MedChemexpress LLC
|
Moxetumomab [CAS 1622075-65-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99034-10mg
|
MedChemexpress LLC
|
Moxetumomab [CAS 1622075-65-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99034-5mg
|
MedChemexpress LLC
|
Moxetumomab [CAS 1622075-65-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0777-10mg
|
MedChemexpress LLC
|
Moxidectin [CAS 113507-06-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0777-5mg
|
MedChemexpress LLC
|
Moxidectin [CAS 113507-06-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0777-50mg
|
MedChemexpress LLC
|
Moxidectin [CAS 113507-06-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0777-1mL
|
MedChemexpress LLC
|
Moxidectin [CAS 113507-06-5] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-66011-100mg
|
MedChemexpress LLC
|
Moxifloxacin (Hydrochloride) [CAS 186826-86-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-66011-50mg
|
MedChemexpress LLC
|
Moxifloxacin (Hydrochloride) [CAS 186826-86-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-66011-500mg
|
MedChemexpress LLC
|
Moxifloxacin (Hydrochloride) [CAS 186826-86-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-66011A-100mg
|
MedChemexpress LLC
|
Moxifloxacin [CAS 151096-09-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-66011A-500mg
|
MedChemexpress LLC
|
Moxifloxacin [CAS 151096-09-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-66011AS3-500ug
|
MedChemexpress LLC
|
Moxifloxacin-d3-1 (hydrochloride) [CAS 1246816-75-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1435-1g
|
MedChemexpress LLC
|
Moxisylyte (hydrochloride) [CAS 964-52-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1435-100mg
|
MedChemexpress LLC
|
Moxisylyte (hydrochloride) [CAS 964-52-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1435-1mL
|
MedChemexpress LLC
|
Moxisylyte (hydrochloride) [CAS 964-52-3] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-115374-100mg
|
MedChemexpress LLC
|
m-PEG6-azide [CAS 1043884-49-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-115374-250mg
|
MedChemexpress LLC
|
m-PEG6-azide [CAS 1043884-49-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-115374-50mg
|
MedChemexpress LLC
|
m-PEG6-azide [CAS 1043884-49-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-133066-100mg
|
MedChemexpress LLC
|
m-PEG6-NHS ester [CAS 1449390-12-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-133066-250mg
|
MedChemexpress LLC
|
m-PEG6-NHS ester [CAS 1449390-12-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-133066-50mg
|
MedChemexpress LLC
|
m-PEG6-NHS ester [CAS 1449390-12-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-W019793-100mg
|
MedChemexpress LLC
|
m-PEG8-NHS ester [CAS 756525-90-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-W019793-50mg
|
MedChemexpress LLC
|
m-PEG8-NHS ester [CAS 756525-90-3]
|
|
COVID-19-immunoregulation
|
|
